A remote Software Development role at myTomorrows. Proficiency in Python programming language
Keywords this role’s ATS scans for
Sydicom tailors your CV and cover letter to match these.
How Sydicom helps: we read this listing’s requirements and tune your CV and cover letter to the keywords its ATS (Ashby) is scanning for, for candidates in Netherlands, then help you apply.
Original listing text, shown exactly as published by the company.
As a Backend Engineer, you will be responsible for developing and maintaining the platform infrastructure that powers our products. You will work closely with our Frontend Engineers, DevOps Engineers, and other stakeholders to design and build scalable, reliable, and high-performance products.
Given that most of our team is located in the Netherlands, we only consider candidates for this position who live within commuting distance to our office in Amsterdam.
We are fully cloud-native, leveraging AWS and adopting a Lean, API-first product development approach driven by modern cloud technologies and thoughtful design practices.
Our backend applications are built using Python, FastAPI, Pydantic, and SQLAlchemy (MySQL). On the front end, we predominantly develop with Angular and also utilize Headless Wagtail and WordPress for select products. To ensure code quality and a consistent release pipeline, we employ GitHub Actions for CI/CD along with tools like Renovate, ruff, Poetry, and pre-commit.
We containerize our applications using Docker and Docker Compose. Currently, we are transitioning from AWS Lambda-based deployments to Kubernetes-managed services and moving from AWS CloudFormation to Terraform for infrastructure as code. We continue to expand our capabilities in knowledge graphs (Neo4j) and database technologies (MySQL, DynamoDB).
myTomorrows
Software Development
18 open roles on Sydicom
myTomorrows is the trade name of Impatients N.V., a globally active healthcare company. The company is based in the Zuidas, Amsterdam, Netherlands. myTomorrows provides patients with unmet medical needs, and their doctors, information about treatment options worldwide and facilitates access to medicines in development. Access to these medicines can be achieved via clinical trials, expanded access and off-label use.
Source: Wikipedia